Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells

Leukemia and Lymphoma

Volumn 45, Issue 9, 2004, Pages 1731-1739

  Aldinucci, Donatella ^a   Lorenzon, Debora ^a   Olivo, Karin ^a   Rapanà, Barbara ^a   Gattei, Valter ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

C kit receptor; Chemokines; Fibroblasts from Hodgkin's disease involved lymph nodes; H RS cell growth

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD40 LIGAND; CHEMOKINE; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 7; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; APOPTOSIS; BIOSYNTHESIS; CANCER CELL; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; EOSINOPHIL; FIBROBLAST; FIBROSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOCOMPETENT CELL; LYMPH NODE; LYMPHATIC SYSTEM DISEASE; MICROENVIRONMENT; MORPHOLOGY; PRIORITY JOURNAL; REED STERNBERG CELL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

FIBROBLASTS; FIBROSIS; GROWTH SUBSTANCES; HODGKIN DISEASE; HUMANS; LYMPH NODES; REED-STERNBERG CELLS;

EID: 3242888905     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001683633     Document Type: Review

References (95)

1. Kadin, M.E. (1994) "Pathology of Hodgkin's disease", Current Opinion in Oncology, 6, 456-463.
2. Harris, N.L. (1999) "Hodgkin's disease: classification and differential diagnosis", Modern Pathology, 12, 159-175.
3. Gruss, H.J., Herrmann, F. and Drexler, H.G. (1994) "Hodgkin's disease: a cytokine-producing tumor", Crit. Rev. Oncog., 5, 473-538.
4. Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., et al. (1995) "Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell line", Blood, 85, 780-789.
5. Skinnider, B.F. and Mak, T.W. (2002) "The role of cytokines in classical Hodgkin lymphoma", Blood, 99, 4283-4297.
6. Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Improta, S., et al. (1996) "Human Eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line", Blood, 88, 3299-3305.
7. Aldinucci, D., Poletto, D., Nanni, P., Degan, M., Gloghini, A., Di Francia, R., et al. (2002) "Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor", Br. J. Haematol., 118, 1055-1064.
8. Aldinucci, D., Poletto, D., Gloghini, A., Nanni, P., Degan, M., Perin, T., et al. (2002) "Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells", Am. J. Pathol., 160, 585-596.
9. Skinnider, B.F., Kapp, U. and Mak, T.W. (2002) "The role of interleukin 13 in classical Hodgkin lymphoma", Leuk. Lymphoma, 43, 1203-1210.
10. Maggio, E., van den Berg, A., Diepstra, A., Kluiver, J., Visser, L. and Poppema, S. (2002) "Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues", Ann. Oncol., 13, 52-56.
11. Fischer, M., Juremalm, M., Olsson, N., Backlin, C., Sundstrom, C., Nilsson, K., et al. (2003) "Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue", Int. J. Cancer, 107, 197-201.
12. Poppema, S. (1996) "Immunology of Hodgkin's disease", Baillieres Clinical Haematology, 9, 447-457.
13. Gruss, H.J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997) "Hodgkin's disease: a tumor with disturbed immunological pathways", Immunology Today, 18, 156-163.
14. Pinto, A., Gattei, V., Zagonel, V., Aldinucci, D., Degan, M., De Iuliis, A., et al. (1998) "Hodgkin's disease: a disorder of dysregulated cellular cross-talk", Biotherapy, 10, 309-320.
15. Gloghini, A., Volpe, R. and Carbone, A. (1990) "Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid tissue", Human Pathology, 21, 792-798.
16. Ohshima, K., Sugihara, M., Suzumiya, J., Haraoka, S., Kanda, M., Shimazaki, K., et al. (1999) "Basic fibroblast growth factor and fibrosis in Hodgkin's disease", Pathol. Res. Pract., 195, 149-155.
17. Ward, P.A. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123-129.
18. Sime, P.J. and O'Reilly, K.M. (2001) "Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment", Clin. Immunol., 99, 308-319.
19. Postlethwaite, A.E., Holness, M.A., Katai, H. and Raghow, R. (1992) "Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4", J. Clin. Invest., 90, 1479-1485.
20. Gillery, P., Fertin, C., Nicolas, J.F., Chastang, F., Kalis, B., Banchereau, J., et al. (1992) "Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis", FEBS Lett., 18, 302, 231-234.
21. Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. and Wynn, T.A. (1999) "An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response", J. Clin. Invest., 104, 777-785.
22. Oriente, A., Fedarko, N.S., Pacocha, S.E., Huang, S.K., Lichtenstein, L.M. and Essayan, D.M. (2000) "Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts" , J. Pharmacol. Exp. Ther., 292, 988-994.
23. Lee, C.G., Homer, R.J., Cohn, L., Link, H., Jung, S., Craft, J.E., et al. (2002) "Transgenic overexpression of interleukin (IL -10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways", J. Biol. Chem., 277, 35466-35474.
24. Gharaee-Kermani, M., Denholm, E.M. and Phan, S.H. (1996) "Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors", J. Biol. Chem., 271, 17779-17784.
25. Gharaee-Kermani, M. and Phan, S.H. (1998) "The role of eosinophils in pulmonary fibrosis", Int. J. Mol. Med., 1, 43-53.
26. Ohshima, K., Akaiwa, M., Umeshita, R., Suzumiya, J., Izuhara, K. and Kikuchi, M. (2001) "Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis", Histopathology, 38, 368-375.
27. Buri, C., Korner, M., Scharli, P., Cefai, D., Uguccioni, M., Mueller, C., et al. (2001) "CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease", Blood, 97, 1543-1548.
28. Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K. and Takizawa, H. (2003) "Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro", Int. Arch. Allergy Immunol., 132, 168-176.
29. Kelly, M., Kolb, M., Bonniaud, P. and Gauldie, J. (2003) "Re-evaluation of fibrogenic cytokines in lung fibrosis", Curr. Pharm. Des., 9, 39-49.
30. Marcopoulou, C.E., Vavouraki, H.N., Dereka, X.E. and Vrotsos, I.A. (2003) "Proliferative effect of growth factors TGF-beta1, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells", J. Int. Acad. Periodontol., 5, 63-70.
31. Takehara, K. (2000) "Growth regulation of skin fibroblasts", J. Dermatol. Sci., 24, (Suppl 1),S70-77.
32. Newcom, S.R. and Gu, L. (1995) "Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease", J. Clin. Pathol., 48, 160-163.
33. Newcom, S.R., Kadin, M.E., Ansari, A.A. and Diehl, V. (1988) "L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH", J. Clin. Invest., 82, 1915-1921.
34. Kadin, M.E., Agnarsson, B., Ellingsworth, L.R. and Newcom, S.R. (1990) "Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease", Am. J. Pathol., 136, 1209-1214.
35. Kadin, M., Butmarc, J., Elovic, A. and Wong, D. (1993) "Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease", Am. J. Pathol., 142, 11-16.
36. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., et al. (1994) "The CD40 antigen and its ligand", Annu. Rev. Immunol., 12, 881-922.
37. Brouty-Boye, D., Pottin-Clemenceau, C., Doucet, C., Jasmin, C. and Azzarone, B. (2000) "Chemokines and CD40 expression in human fibroblasts", Eur. J. Immunol., 30, 914-919.
38. Fries, K.M., Sempowski, G.D., Gaspari, A.A., Blieden, T., Looney, R.J. and Phipps, R.P. (1995) "CD40 expression by human fibroblasts", Clin. Immunol. Immunopathol., 77, 42-51.
39. Ward, P.A. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123-129.
40. Companjen, A.R., van der Wel, L.I., Boon, L., Prens, E.P. and Laman, J. D. (2002) "CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1", Int. Immunol., 14, 669-676.
41. Wassenaar, A., Verschoor, T., Kievits, F., Den Hartog, M.T., Kapsenberg, M.L., Everts, V., et al. (1999) "CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts", Clin. Exp. Immunol., 115, 161-167.
42. King, A.E., Kelly, R.W., Critchley, H.O.D., Malmstrom, A., Sennstrom, M. and Phipps, R.P. (2001) "CD40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts", J. Clin. Endocrinol. MeTable., 86, 405-412.
43. Yellin, M.J., Winikoff, S., Fortune, S.M., Baum, D., Crow, M.K., Lederman, S., et al. (1995) "Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation", J. Leukoc. Biol., 58, 209-211.
44. Atamas, S.P., Luzina, I.G., Dai, H., Wilt, S.G. and White, B. (2002) "Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signalling", J. Immunol., 168, 1139-1145.
45. Zhang, Y., Cao, H.J., Graf, B., Meekins, H., Smith, T.J. and Phipps, R.P. (1998). "CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts", J. Immunol., 160, 1053-1057.
46. Betz, M. and Fox, B.S. (1995) "Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines", J. Immunol., 146, 108-113.
47. Clodi, K., Asgari, Z., Younes, M., Palmer, J.L., Cabanillas, F., Carbone, A., et al. (2002) "Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance", Cancer, 94, 1-5.
48. Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Perin, V., et al., (1997) "The role of eosinophils in the pathobiology of Hodgkin's disease", Ann. Oncol., 8, 89-96.
49. Molin, D., Edstrom, A., Glimelius, I., Glimelius, B., Nilsson, G., Sundstrom, C., et al. (2002) "Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma", Br. J. Haematol., 119, 122-124.
50. Hartman, M.L., Piliponsky, A.M., Temkin, V. and Levi-Schaffer, F. (2001) "Human peripheral blood eosinophils express stem cell factor", Blood, 97, 1086-1091.
51. Bargou, R.C., Mapara, M.Y., Zugck, C., Daniel, P.T., Pawlita, M., Dohner, H., et al. (1993) "Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice", J. Exp. Med., 177, 1257-1268.
52. Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297-303.
53. Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., et al. (2001) "STAT3 is constitutively activated in Hodgkin cell lines", Blood, 98, 762-770.
54. Ashman, L.K. (1999) "The biology of stem cell factor and its receptor C-kit", International Journal of Biochemistry and Cell Biology, 31, 1037-1051.
55. Broudy, V.C. (1997) "Stem cell factor and hematopoiesis", Blood, 90, 1345-1364.
56. Broxmeyer, H.E., Maze, R., Miyazawa, K., Carow, C., Hendrie, P.C., Cooper, S., et al. (1991) "The kit receptor and its ligand, steel factor, as regulators of hemopoiesis", Cancer Cells, 3, 480-487.
57. Mierke, C.T., Ballmaier, M., Werner, U., Manns, M.P., Welte, K. and Bischoff, S.C. (2000) "Human endothelial cells regulate survival and proliferation of human mast cells", Journal of Experimental Medicine, 192, 801-811.
58. Avraham, H., Scadden, D.T., Chi, S., Broudy, V.C., Zsebo, K.M. and Groopman, J.E. (1992) "Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand", Blood, 80, 1679-1684.
59. Gattei, V., Aldinucci, D., Quinn, J.M., Degan, M., Cozzi, M., Perin, V., et al. (1996) "Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor", Cell Growth & Differentiation, 7, 753-763.
60. Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M.R., Ludwig, W.D., et al. (1992) "Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors", Blood, 80, 1199-1206.
61. Timeus, F., Crescenzio, N., Valle, P., Pistamiglio, P., Piglione, M., Garelli, E., et al. (1997) "Stem cell factor suppresses apoptosis in neuroblastoma cell lines", Experimental Haematology, 25, 1253-1260.
62. Ricotti, E., Fagioli, F., Garelli, E., Linari, C., Crescenzio, N., Horenstein, A.L., et al. (1998) "c-kit is expressed in Soft Tissue Sarcoma of neuroectodermis origin and its ligand prevents apoptosis of neoplastic cells", Blood, 91, 2397-2405.
63. Landuzzi, L., De Giovanni, C., Nicoletti, G., Rossi, I., Ricci, C., Astolfi, A., et al. (2000) "The metastatic ability of Ewing's sarcoma cells is modulated by Stem Cell Factor and by its receptor c-kit", American Journal of Pathology, 157, 2123-2131.
64. Pinto, A., Gloghini, A., Gattei, V., Aldinucci, D., Zagonel, V. and Carbone, A. (1994) "Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30 + anaplastic large cell lymphomas", Blood, 83, 785-792.
65. Gruss, H.J., Brach, M.A., Drexler, H.G., Bross, K.J. and Herrmann, F. (1992) "Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells", Cancer Research, 52, 1026-1031.
66. Merz, H., Houssiau, F.A., Orscheschek, K., Renauld, J.F., Fliedner, A., Herin, M., et al. (1991) "Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma", Blood, 78, 1311-1317.
67. Aldinucci, D. and Gattei, V. (2003) "The role of interleukin-3 and stem cell factor in classical Hodgkin disease", Blood, 101, 376-377.
68. Gommerman, J.L. and Berger, S.A. (1998) "Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx", Blood, 91, 1891-1900.
69. Fry, T.J. and Mackall, C.L. (2002) "Interleukin-7: from bench to clinic", Blood, 99, 3892-38904.
70. Foss, H.D., Hummel, M., Gottstein, S., Ziemann, K., Falini, B., Herbst, H., et al., (1995) "Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease", Am J Pathol., 146, 33-39.
71. Trumper, L., Jung, W., Dahl, G., Diehl, V., Gause, A. and Pfreundschuh, M. (1994) "Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease", Ann. Oncol., 5, 93-96.
72. Gorschluter, M., Bohlen, H., Hasenclever, D., Diehl, V. and Tesch, H. (1995) "Serum cytokine levels correlate with clinical parameters in Hodgkin's disease", Ann. Oncol., 6, 477-482.
73. Touw, I., Pouwels, K., van Agthoven, T., van Gurp, R., Budel, L., Hoogerbrugge, H., et al. (1990) "Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia", Blood, 75, 2097-2101.
74. Hsu, S.M., Waldron, J., Xie, S.S. and Hsu, P.L. (1995) "Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas", J. Biomed. Sci., 2, 302-313.
75. Kishimoto, T., Akira, S., Narazaki, M. and Taga, T. (1995) "Interleukin-6 family of cytokines and gp130", Blood, 86, 1243-1254.
76. Klein, B., Tarte, K., Jourdan, M., Mathouk, K., Moreaux, J., Jourdan, E., et al. (2003) "Survival and proliferation factors of normal and malignant plasma cells", Int. J. Hematol., 78, 106-113.
77. Trikha, M., Corringham, R., Klein, B. and Rossi, J.F. (2003) "Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence", Clin. Cancer Res., 9, 4653-4665.
78. Reynolds, G.M., Billingham, L.J., Gray, L.J., Flavell, J.R., Najafipour, S., Crocker, J., et al. (2002) "Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease", Br. J. Haematol., 118, 195-201.
79. Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297-303.
80. Iwata, M., Graf, L., Awaya, N. and Torok-Storb, B. (2002) "Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein", Blood, 100, 1318-1325.
81. Teruya-Feldstein, J., Tosato, G. and Jaffe, E.S. (2000) "The role of chemokines in Hodgkin's disease", Leuk. Lymphoma, 38, 363-371.
82. Romagnani, S. (2002) "Cytokines and chemoattractants in allergic inflammation", Mol. Immunol., 38, 881-885.
83. Teruya-Feldstein, J., Jaffe, E.S., Burd, P.R., Kingma, D.W., Setsuda, J.E. and Tosato, G. (1999) "Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia", Blood, 93, 2463-2470.
84. Jundt, F., Anagnostopoulos, I., Bommert, K., Emmerich, F., Muller, G., Foss, H.D., et al. (1999) "Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils", Blood, 94, 2065-2071.
85. Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P., et al. (1999) "Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta)", Proc. Natl. Acad. Sci. USA, 96, 9660-9665.
86. Axdorph, U., Porwit-MacDonald, A., Grimfors, G. and Bjorkholm, M. (2001) "Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease", Leuk. Lymphoma, 42, 1055-1065.
87. van Roozendaal, C.E., van Ooijen, B., Klijn, J.G., Claassen, C., Eggermont, A.M., Henzen-Logmans, S.C., et al. (1998) "Stromal influences on breast cancer cell growth", Br. J. Cancer, 65, 77-81.
88. Gache, C., Berthois, Y., Cvitkovic, E., Martin, P.M. and Saez, S. (1999) "Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25-dihydroxyvitamin D3", Breast Cancer Res. Treat., 55, 29-39.
89. Gache, C., Berthois, Y., Martin, P.M. and Saez, S. (1998) "Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture", In Vitro Cell Dev. Biol. Anim., 34, 347-351.
90. Noel, A. and Foidart, J.M. (1998) "The role of stroma in breast carcinoma growth in vivo", J. Mammary Gland Biol. Neoplasia, 3, 215-225.
91. Cunha, G.R., Hayward, S.W. Wang, Y.Z. and Ricke, W.A. (2003) "Role of the stromal microenvironment in carcinogenesis of the prostate", Int. J. Cancer, 20, 107, 1-10.
92. De Wever, O. and Mareel, M. (2003) "Role of tissue stroma in cancer cell invasion", J. Pathol., 200, 429-447.
93. Moinfar, F., Man, Y.G., Arnould, L., Bratthauer, G.L., Ratschek, M. and Tavassoli, F.A. (2000) "Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis", Cancer Res., 60, 2562-2566.
94. Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryckmans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387-2396.
95. Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V. (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", Br. J. Haematol., 92, 97-103.